losartan potassium
losartan potassium
Pharmacologic class: Angiotensin II receptor antagonist
Therapeutic class: Antihypertensive
Pregnancy risk category C (first trimester), D (second and third trimesters)
FDA Box Warning
• When used during second or third trimester of pregnancy, drug may cause fetal harm or death. Discontinue as soon as pregnancy is detected.
Action
Blocks vasoconstricting and aldosterone-secreting effects of angiotensin II at various receptor sites, including vascular smooth muscle and adrenal glands. Also increases urinary flow and enhances excretion of chloride, magnesium, calcium, and phosphate.
Availability
Tablets: 25 mg, 50 mg, 100 mg
Indications and dosages
➣ Hypertension
Adults: Initially, 50 mg/day P.O.; range is 25 to 100 mg/day as a single dose or in two divided doses. May be used alone or with other drugs.
Children ages 6 and older: 0.7 mg/kg P.O. daily, up to total of 50 mg
➣ To prevent cerebrovascular accident (stroke) in hypertensive patients with left ventricular hypertrophy (LVH)
Adults: Initially, 50 mg P.O. daily, increased to 100 mg P.O. daily. May be given concurrently with hydrochlorothiazide.
➣ Nephropathy in patients with type 2 diabetes
Adults: 50 mg/day P.O.; increase to 100 mg/day based on blood pressure response.
Dosage adjustment
• Hepatic impairment
• Concurrent diuretic therapy
Contraindications
• Hypersensitivity to drug or its components
• Pregnancy (second and third trimesters)
Precautions
Use cautiously in:
• heart failure, renal or hepatic impairment, obstructive biliary disorders
• high-dose diuretic therapy
• black patients
• pregnant patients (first trimester) or breastfeeding patients
• children younger than age 6 (safety not established).
Administration
• Administer with or without food.
• Know that if drug efficacy (measured at trough) is inadequate with once-daily dosing, prescriber may switch to twice-daily regimen using same or higher daily dosage.
• Be aware that drug may take 3 to 6 weeks to reach maximal efficacy.
Adverse reactions
CNS: dizziness, insomnia, headache, asthenia, fatigue
CV: hypotension
EENT: sinus disorders
GI: nausea, vomiting, diarrhea, dyspepsia, abdominal pain
Metabolic: hyperkalemia
Musculoskeletal: joint pain, back pain, muscle cramps
Respiratory: symptoms of upper respiratory infection, dry cough
Other: hypersensitivity reactions including angioedema
Interactions
Drug-drug. Diuretics, other antihypertensives: increased risk of hypotension
Fluconazole: inhibited losartan metabolism, increased antihypertensive effects
Indomethacin: decreased losartan effects
Lithium: decreased lithium metabolism
Nonsteroidal anti-inflammatory drugs: decreased renal function
Potassium-sparing diuretics, potassium supplements: hyperkalemia
Rifamycins: enhanced losartan metabolism, decreased antihypertensive effects
Drug-diagnostic tests. Albumin: increased level
Drug-food. Salt substitutes containing potassium: hyperkalemia
Patient monitoring
See Watch for angioedema and other hypersensitivity reactions.
• Monitor blood pressure to evaluate drug efficacy.
• Assess liver and kidney function tests and electrolyte levels.
• Stay alert for oliguria, progressive azotemia, and renal failure in patients with severe heart failure whose renal function depends on the renin-angiotensin-aldosterone system.
• Know that in black patients, losartan and other ACE inhibitors may be ineffective when used alone. Drug isn't indicated for stroke prevention in black hypertensive patients with LVH.
• Be aware that drug may cause fetal injury or death when used during second or third trimester of pregnancy.
Patient teaching
• Instruct patient to avoid potassium supplements and salt substitutes containing potassium, unless directed by prescriber.
See Caution female patient not to take drug during second or third trimester of pregnancy. Advise her to contact prescriber immediately if she suspects pregnancy.
• Tell female patient to discuss breastfeeding with prescriber before taking.
See Instruct patient to immediately report hypersensitivity reactions, especially lip or eyelid swelling, throat tightness, and difficulty breathing.
• As appropriate, review all other significant and life-threatening adverse reactions and interactions, especially those related to the drugs, tests, and foods mentioned above.